Cargando…

Effect of SKF-96365 on cardiomyocyte hypertrophy induced by angiotensin II

Angiotensin II (Ang II) is an important bioactive peptide in the renin-angiotensin system, and it can contribute to cell proliferation and cardiac hypertrophy. Dysfunctions in transient receptor potential canonical (TRPC) channels are involved in many types of cardiovascular diseases. The aim of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Huijun, Li, Jiaoxia, Wu, Qiyan, Zheng, Xiaodong, Gao, Yongqiang, Yang, Qiaofen, Sun, Ningxi, He, Meiqiong, Zhou, Youjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947876/ https://www.ncbi.nlm.nih.gov/pubmed/31974621 http://dx.doi.org/10.3892/mmr.2019.10877

Ejemplares similares

Therapeutic effects of SKF-96365 on murine allergic rhinitis induced by OVA
por: Ba, Guangyi, et al.
Publicado: (2021)

SKF96365 impedes spinal glutamatergic transmission-mediated neuropathic allodynia
por: Wang, Qiru, et al.
Publicado: (2023)

SKF96365 modulates activity of CatSper channels in human sperm
por: Torrezan-Nitao, Elis, et al.
Publicado: (2023)

Inhibitory effects of SKF96365 on the activities of K(+) channels in mouse small intestinal smooth muscle cells
por: TANAHASHI, Yasuyuki, et al.
Publicado: (2015)

Multiple ion channel block by the cation channel inhibitor SKF‐96365 in myocytes from the rabbit atrioventricular node
por: Cheng, Hongwei, et al.
Publicado: (2016)

Preliminary Structure-Activity Relationship (SAR) of a Novel Series of Pyrazole SKF-96365 Analogues as Potential Store-Operated Calcium Entry (SOCE) Inhibitors
por: Dago, Camille D., et al.
Publicado: (2018)

Protective Effects of SKF-96365, a Non-Specific Inhibitor of SOCE, against MPP(+)-Induced Cytotoxicity in PC12 Cells: Potential Role of Homer1
por: Chen, Tao, et al.
Publicado: (2013)

SKF : catálogo general.
Publicado: (1989)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
por: Chen, Ai-Lan, et al.
Publicado: (2012)

SKF Award Ceremony
por: Zinsou, Lionel, et al.
Publicado: (2019)

Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation
por: Zheng, Liuying, et al.
Publicado: (2022)

The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II
por: GUO, HUIXIN, et al.
Publicado: (2015)

Nelumbo nucifera Receptaculum Extract Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
por: Cho, Soyoung, et al.
Publicado: (2019)

Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
por: Hernández, Jessica Soto, et al.
Publicado: (2014)

Crim1 inhibits angiotensin II-induced hypertrophy and preserves Kv4.2 expression in cardiomyocytes
por: He, Jionghong, et al.
Publicado: (2022)

Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress
por: Gao, Yan, et al.
Publicado: (2021)

Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation
por: Chen, Ci, et al.
Publicado: (2014)

An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy
por: Wu, Teng, et al.
Publicado: (2020)

Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway
por: Du, Fawang, et al.
Publicado: (2021)

Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes
por: Chao, Hung-Hsing, et al.
Publicado: (2014)

SIRT1 Functions as an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy
por: Shen, Tao, et al.
Publicado: (2014)

Corrigendum: An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy
por: Wu, Teng, et al.
Publicado: (2021)

Prolactin and fMRI response to SKF38393 in the baboon
por: Miller, Brad, et al.
Publicado: (2013)

The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity
por: Li, Jie, et al.
Publicado: (2017)

SKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca(2+) signaling in nasopharyngeal carcinoma cells
por: Zhang, Jinyan, et al.
Publicado: (2015)

Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
por: Flores-Muñoz, Monica, et al.
Publicado: (2012)

Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling
por: Chen, Yuezhang, et al.
Publicado: (2017)

Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect
por: Tashiro, Kohei, et al.
Publicado: (2020)

Catalase Mediates the Inhibitory Actions of PPARδ against Angiotensin II-Triggered Hypertrophy in H9c2 Cardiomyocytes
por: Hwang, Jung Seok, et al.
Publicado: (2021)

Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy
por: Siti, Hawa Nordin, et al.
Publicado: (2021)

Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway
por: Mo, Jiajia, et al.
Publicado: (2022)

Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
por: Li, Yiping, et al.
Publicado: (2019)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

DDA-SKF: Predicting Drug–Disease Associations Using Similarity Kernel Fusion
por: Gao, Chu-Qiao, et al.
Publicado: (2022)

Direct Actions of AT(1) (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy
por: Sparks, Matthew A., et al.
Publicado: (2021)

Deficit of glucocorticoid‐induced leucine zipper amplifies angiotensin‐induced cardiomyocyte hypertrophy and diastolic dysfunction
por: Cappetta, Donato, et al.
Publicado: (2020)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

CD38 promotes angiotensin II‐induced cardiac hypertrophy
por: Guan, Xiao‐Hui, et al.
Publicado: (2017)

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
por: Bhullar, Sukhwinder K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6fj6tq9n8363ffu8um8gnt639k